MSCA Postdoctoral Fellowship with RCSI
Apply for a Marie Skłodowska-Curie Actions Postdoctoral Fellowship (MSCA PF) with RCSI as your host institution. We actively support researchers to shape a strong proposal, identify the right supervisor, and develop a clear training and career plan.
MSCA Postdoctoral Fellowships are funded by the European Commission under Horizon Europe. They support excellent postdoctoral researchers through advanced training and international mobility, helping strengthen research profiles and long-term career progression.
We have hosted more than 60 MSCA Fellows over the past 10 years and has an application success rate double the EU average.
Key features include:
- A joint application with a supervisor
- European and global fellowship options
- Funding for salary, mobility, training and research costs.

Why choose RCSI as your host institution?
RCSI is focused on research and education that improves human health. We are an independent, not-for-profit education and research institution based in Dublin with research across medicine and health sciences, with a focus on improving human health through translational research.
We will help you to identify a suitable supervisor and research environment and our Office of Research and Innovation provides structured proposal support.
Key strengths include:
- A strong focus on translational research.
- A health science-focused research environment.
- Strategic research themes spanning biomaterials, medical devices and pharmaceutical sciences, cancer, neurological and psychiatric disorders, population health and health services, surgical science and practice, vascular biology and cardiology, and respiratory and critical care.
- Strong links with acute hospitals.
- A commitment to improving health and well-being aligned with the United Nations Sustainable Development Goals – RCSI ranked first in the world in 2025 under SDG 3, Good Health and Well-being.
Who can apply?
Promising researchers of any nationality who:
- Are in possession of a PhD at the call deadline;
- Have a maximum of eight years’ full time equivalent research experience post PhD*; and
- Have not lived or worked in Ireland (European Fellowship) or the country of the outgoing host organisation (Global Fellowship) for more than 12 months in the 36 months prior to the call deadline.
*Years of experience outside research and career breaks will not count towards this maximum, nor will research experience in third countries for nationals or long term residents of EU Member States or Horizon Europe associated countries wishing to reintegrate to Europe.
Please consult the official MSCA Postdoctoral Fellowships call documentation for full eligibility criteria.
How RCSI supports your application
The RCSI Office of Research and Innovation provides structured support to selected MSCA PF candidates, including:
- Eligibility checks
- Supervisor identification and fit advice
- Proposal development support
- Alignment with EU and institutional priorities
- Career development and training advice
- Ongoing guidance through the application process
How to get started
- Review our research themes and assess fit with your research idea.
- Identify, or seek help finding, a suitable supervisor at RCSI.
- Submit an expression of interest, including a CV and a short summary of your research interests, to eufunding@rcsi.ie.
- Work with your supervisor and the RCSI MSCA PF Research Officer to develop your proposal.
Contact us
We encourage early contact from interested researchers.
Email: eufunding@rcsi.ie.
The following RCSI-based principal investigators (PIs) have expressed an interest in supporting enthusiastic and talented postdoctoral researchers who wish to apply for an MSCA Postdoctoral Fellowship.
| PI | School/Department | Areas of research interest for MSCA PF supervision |
| Oran Kennedy |
Tissue Engineering Research Group (TERG), Department of Anatomy and Regenerative Medicine | Biomaterials, musculoskeletal medicine, bone, cartilage, osteocytes, osteoarthritis, synovitis, drug delivery |
| Shane Browne |
Tissue Engineering Research Group (TERG), Department of Anatomy and Regenerative Medicine | Injectable hydrogels, hyaluronic acid, wound repair, cell and therapeutic delivery, in vitro models, vascularisation |
| Tom Hodgkinson |
Tissue Engineering Research Group (TERG), Department of Anatomy and Regenerative Medicine | Osteochondral regeneration, cell engineering, synthetic biology, epigenetics, ageing, biomaterials, additive manufacturing, 3D printing, melt electrowriting |
| Grace O'Malley |
School of Physiotherapy | Digital healthcare, AI in telemedicine |
| Ali Hasnain |
School of Pharmacy and Biomolecular Sciences | Use of AI (conversational and GenAI) in healthcare. Digital health and artificial intelligence. Use of healthcare data and genomics and personalised medicine. |
| Frank Moriarty |
School of Pharmacy and Biomolecular Sciences | Pharmacoepidemiology, appropriate prescribing and deprescribing, pharmaceutical policy, pharmacovigilance, management of chronic disease, primary care. |
| Jennifer Dowling |
School of Pharmacy and Biomolecular Sciences | Immunometabolism, multiple sclerosis, brain metastasis |
| Michelle Flood |
School of Pharmacy and Biomolecular Sciences | Patient and public involvement and engagement. Co-design in health services research. |
| Roger Preston |
School of Pharmacy and Biomolecular Sciences | Blood coagulation, immunity, thrombosis. |
| Sudipto Das | School of Pharmacy and Biomolecular Sciences | Epigenetics, personalised/precision medicine, cancer, gastrointestinal diseases, inflammation, genomics, AI/machine learning |
| Aisling Walsh |
Public Health and Epidemiology | Maternal health services research, from pre-conception to postpartum and for women with chronic conditions and disability, as well as a focus on marginalised groups. |
| Edward Gregg |
Population Health | Epidemiology and prevention of diabetes, chronic conditions, and multiple long-term conditions. Global health aspects of non-communicable diseases. Impact of lifestyle and related health services interventions. |
| Alan Maddock |
Health Psychology | Mindfulness-based interventions for mental health and well-being outcomes. Mental health intervention research, including digital interventions. Supporting youth mental health. Supporting persons experiencing homelessness. |
| Frank Doyle |
Health Psychology | Psychometrics tobacco/vaping, evidence synthesis (e.g. network meta-analysis), merging population health databases |
| Maria Pertl | Health Psychology | Cancer survivorship, mental health, dementia and caregiving, down syndrome, lifestyle medicine |
| Mary Clarke | Health Psychology | Early identification and prevention of risk for later mental illness, especially risk and prognostic factors in the perinatal and early childhood period. The impact of childhood trauma on mental health and wellbeing and trauma-informed education and policy. |
| John-Paul Byrne |
Graduate School of Healthcare Management | Social determinants of healthcare work. Working conditions and well-being in health. Psychosocial work environments. Ethnographic and qualitative methods. |
| Éidín Ní Shé |
Graduate School of Healthcare Management | Co-design healthcare,management, care of older people |
| Niamh Humphries |
Graduate School of Healthcare Management | Health workforce research, health worker retention, health workers migration |
| Ann Hopkins | Department of Surgery | JAM-A as a novel druggable target in various cancers. Companion blood biomarkers of oncological disease progression. Immunocompetent non-animal models to model cancer progression and treatment. |
| Melanie Foecking | Department of Psychiatry | Schizophrenia, depression, biomarker, inflammation, synaptic transmission, nutritional psychiatry. |
| Patrick Redmond | Department of General Practice | Early detection pathways, such as screening programmes and mobile health interventions. Leveraging digital health and AI for epidemiological studies, AI-driven support tools and NLP models. Implementation science, such as trialling cancer prevention strategies and translating research to policy. Primary care-based clinical trials of new diagnostics and interventions |
| Caitriona Cahir | Data Science Centre, School of Population Health |
Epidemiology and population health. All areas are welcome. I work on research across chronic diseases (in particular cancer and older populations) and have done a lot of research around medication management and health outcomes, as well as investigating social determinants of health and other risk factors associated with population health outcomes. I use both quantitative and qualitative research methodologies. |
| Kathleen Bennett | Data Science Centre, School of Population Health | Cancer epidemiology, chronic disease epidemiology and pharmacoepidemiology. Application of data analytics to healthcare. |
| Marc Devocelle | Chemistry | Green peptide synthesis. Synthesis and modification of antimicrobial peptides, used as antibiotic candidates and/or antibiofilm coatings. |
| Natalie McEvoy | Anaesthesia and Critical Care | Neurocritical care, organ donation, ARDS, quantitative and qualitative research methods. |